Deutetrabenazin

Deutetrabenazin is a medication used to treat restless legs syndrome (RLS), a neurological disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. It is also used to treat periodic limb movement disorder (PLMD), a condition where people experience repetitive, involuntary movements in their limbs, typically during sleep. Deutetrabenazin works by increasing the levels of dopamine in the brain, which helps to reduce the symptoms of RLS and PLMD.

The medication is available in tablet form and is typically taken once or twice a day, depending on the severity of the symptoms. It is important to follow the dosage instructions provided by a healthcare professional to ensure the medication is effective and to minimize the risk of side effects. Common side effects of deutetrabenazin include dizziness, drowsiness, and nausea. More serious side effects, such as seizures, are rare but can occur.

Deutetrabenazin was first approved for medical use in the United States in 2004. It is manufactured by several pharmaceutical companies, including Teva Pharmaceuticals and Sun Pharmaceuticals. The medication is available by prescription only and should be used under the supervision of a healthcare professional. As with any medication, it is important to discuss the potential benefits and risks of deutetrabenazin with a healthcare provider before starting treatment.